Comparing imaging techniques for diagnosing gastric cancer
Preliminary Study on the Diagnostic Value Comparison of 18F-FAPI-04 PET/CT and PET/MR in Gastric Cancer
Hunan Cancer Hospital · NCT06543108
This study is testing if a new type of imaging combined with blood tests can better diagnose gastric cancer and its spread in patients already diagnosed with the disease.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 30 (estimated) |
| Ages | 18 Years to 90 Years |
| Sex | All |
| Sponsor | Hunan Cancer Hospital (other) |
| Locations | 1 site (Changsha, Hunan) |
| Trial ID | NCT06543108 on ClinicalTrials.gov |
What this trial studies
This project aims to analyze the diagnostic efficacy of 18F-FAPI-04 PET/CT imaging combined with serum tumor markers in gastric cancer. It will evaluate the effectiveness of both PET/CT and PET/MR imaging in assessing peritoneal metastasis and construct a molecular imaging diagnostic model for gastric cancer. The study will involve patients diagnosed with gastric cancer who will undergo imaging and tumor marker testing within a specified timeframe.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 years old who have been diagnosed with gastric cancer and can undergo the required imaging procedures.
Not a fit: Patients with a history of other malignant tumors or severe underlying health conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the accuracy of gastric cancer diagnosis and staging, leading to better treatment outcomes.
How similar studies have performed: While the specific approach of using 18F-FAPI-04 PET/CT is novel, similar imaging techniques have shown promise in other studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age over 18 years old; 2. Diagnosed as a patient with gastric cancer; 3. Receive FAPI PET/CT and FDG PET/CT imaging within one week; 4. Perform serum tumor marker testing one week before and after scanning Exclusion Criteria: 1. History of other malignant tumors; 2. Patients with severe infections, severe underlying diseases such as heart, kidney, and liver; 3. Patients with contraindications for PET-CT examination, poor physical condition, and inability to tolerate the examination; 4. Patients with unorganized pathology or incomplete clinical data
Where this trial is running
Changsha, Hunan
- Hunan Cancer hospital — Changsha, Hunan, China (RECRUITING)
Study contacts
- Study coordinator: Hui Ye
- Email: yuxin75831@163.com
- Phone: 86-13755117105
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Gastric Cancer